Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11944623 Modulators of Kv3 channels to treat pain

Patent 11944623 was granted and assigned to Autifony Therapeutics Limited on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Autifony Therapeutics Limited

Current Assignee

Autifony Therapeutics Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119446230

Patent Inventor Names

Charles Large0

Giuseppe Alvaro0

Date of Patent

April 2, 2024

Patent Application Number

174724930

Date Filed

September 10, 2021

Patent Citations

‌

US Patent 9346790 Hydantoin derivatives useful as Kv3 inhibitors

‌

US Patent 9133175 Compounds

‌

US Patent 10098881 Compounds

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11944623 Modulators of Kv3 channels to treat pain

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API